Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients

Journal of Pain

Volumn 7, Issue 2, 2006, Pages 75-81

  Bijur, Polly E ^a   Schechter, Clyde ^a   Esses, David ^a   Chang, Andrew K ^a   Gallagher, E John ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Analgesia; Emergency medicine; Morphine; Naloxone; Pain management

Indexed keywords

MORPHINE; NALOXONE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EMERGENCY CARE; EMERGENCY WARD; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

ACUTE DISEASE; ADULT; AGED; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; TREATMENT FAILURE;

EID: 32044433549     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2005.08.008     Document Type: Article

References (19)

1. F. Aubrun, O. Langeron, C. Quesnel, P. Coriat, B. Riou Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration Anesthesiology 98 2003 1415 1421
2. P.E. Bijur, M.K. Kenny, E.J. Gallagher Intravenous morphine at 0.1 mg/kg is not effective for controlling severe acute pain in the majority of patients Ann Emerg Med 46 2005 362 367
3. M.S. Cepeda, J.M. Africano, A.M. Manrique, W. Fragoso, D.B. Carr The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period Pain 96 2002 73 79
4. M.S. Cepeda, H. Alvarez, O. Morales, D.B. Carr Addition of ultralow dose naloxone to postoperative morphine PCA unchanged analgesia and opioid requirement but decreased incidence of opioid side effects Pain 107 2004 41 46
5. S.M. Crain, K.F. Shen Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons Trends Pharmacol Sci 11 1990 77 81
6. S.M. Crain, K.F. Shen Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment Proc Natl Acad Sci U S A 92 1995 10540 10544
7. S.M. Crain, K.F. Shen Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions Trends Pharmacol Sci 9 1998 358 365
8. S.M. Crain, K.F. Shen Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability Pain 84 2000 121 131
9. T.J. Gan, B. Ginsberg, P.S. Glass, J. Fortney, R. Jhaveri, R. Perno Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate Anesthesiology 87 1997 1075 1081
10. J.P. Gonzalez, R.N. Brogden Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence Drugs 35 1988 192 213
11. J. Jaffe, W. Martin Opioid analgesics and antagonists A.G. Gilman T.W. Rall A.S. Nies The Pharmacological Basis of Therapeutics 8th ed. 1990 Pergamon New York, NY 485 521
12. A.M. Kelly Setting the benchmark for research in the management of acute pain in emergency departments Emerg Med 13 2001 57 60
13. J.G. MacKinnon, H. White Some heteroskedasticity consistent covariance matrix estimators with improved finite sample properties J Econometrics 29 1985 305 325
14. L.F. McCaig, C.W. Burt National Hospital Ambulatory Medical Care Survey 2002 emergency department summary Advance Data 2004 1 34
15. K.J. Powell, N.S. Abul-Husn, A. Jhamandas, M.C. Olmstead, R.J. Beninger, K. Jhamandas Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats J Pharmacol Exp Ther 300 2002 588 596
16. T. Rupp, K.A. Delaney Inadequate analgesia in emergency medicine Ann Emerg Med 43 2004 494 503
17. K.F. Shen, S.M. Crain Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells J Neurosci 14 1994 5570 5579
18. K.F. Shen, S.M. Crain Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice Brain Res 757 1997 176 190
19. H. Suarez-Roca, W. Maixner Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices J Pharmacol Exp Ther 264 1993 648 653